[HTML] nih.gov

[HTML][HTML] Direct comparison of low-dose dabigatran and rivaroxaban for effectiveness and safety in patients with non-valvular atrial fibrillation

SW Meng, TT Lin, MT Liao, HM Chen… - Acta Cardiologica …, 2019 - ncbi.nlm.nih.gov
Background We aimed to examine the comparative effectiveness and safety between low-
dose dabigatran and rivaroxaban in atrial fibrillation (AF) patients. Methods Using the …
被引用次数：11 相关文章

Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation.

SW Meng, TT Lin, MT Liao, HM Chen… - Acta Cardiologica …, 2019 - europepmc.org
Background We aimed to examine the comparative effectiveness and safety between low-
dose dabigatran and rivaroxaban in atrial fibrillation (AF) patients. Methods Using the …

Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation

SW Meng, TT Lin, MT Liao… - Acta Cardiologica …, 2019 - pubmed.ncbi.nlm.nih.gov
Background We aimed to examine the comparative effectiveness and safety between low-
dose dabigatran and rivaroxaban in atrial fibrillation (AF) patients. Methods Using the …

Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation

SW Meng, TT Lin, MT Liao, HM Chen… - Acta Cardiologica …, 2019 - airitilibrary.com
Background: We aimed to examine the comparative effectiveness and safety between low-
dose dabigatran and rivaroxaban in atrial fibrillation (AF) patients. Methods: Using the …